NO911237L - Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner - Google Patents

Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner

Info

Publication number
NO911237L
NO911237L NO91911237A NO911237A NO911237L NO 911237 L NO911237 L NO 911237L NO 91911237 A NO91911237 A NO 91911237A NO 911237 A NO911237 A NO 911237A NO 911237 L NO911237 L NO 911237L
Authority
NO
Norway
Prior art keywords
indolizidines
quinolizidines
hydroxymethyl
procedure
preparation
Prior art date
Application number
NO91911237A
Other languages
English (en)
Norwegian (no)
Other versions
NO911237D0 (no
Inventor
Paul Saiho Liu
Mohinder Singh Kang
Roland Stephen Rogers
Bary Lee Rhinehart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO911237D0 publication Critical patent/NO911237D0/no
Publication of NO911237L publication Critical patent/NO911237L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO91911237A 1990-03-30 1991-03-26 Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner NO911237L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/502,602 US5028614A (en) 1990-03-30 1990-03-30 Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors

Publications (2)

Publication Number Publication Date
NO911237D0 NO911237D0 (no) 1991-03-26
NO911237L true NO911237L (no) 1991-10-01

Family

ID=23998556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911237A NO911237L (no) 1990-03-30 1991-03-26 Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner

Country Status (18)

Country Link
US (1) US5028614A (fr)
EP (1) EP0449294B1 (fr)
JP (1) JP3019270B2 (fr)
KR (1) KR100195422B1 (fr)
CN (1) CN1055362A (fr)
AT (1) ATE140228T1 (fr)
AU (1) AU638318B2 (fr)
CA (1) CA2038984C (fr)
DE (1) DE69120705T2 (fr)
ES (1) ES2093040T3 (fr)
FI (1) FI911510A (fr)
HU (1) HU208974B (fr)
IE (1) IE911063A1 (fr)
IL (1) IL97698A0 (fr)
NO (1) NO911237L (fr)
NZ (1) NZ237567A (fr)
PT (1) PT97201A (fr)
ZA (1) ZA912236B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152054A (en) * 1990-05-25 1992-10-06 Seiko Epson Corporation Method of making film carrier structure for integrated circuit tape automated bonding
US5273981A (en) * 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
AU668691B2 (en) * 1991-08-09 1996-05-16 Nycomed Innovation Ab Use of persistent free-radicals in magnetic resonance imaging
EP0738498A1 (fr) * 1995-04-18 1996-10-23 Machida Endoscope Co., Ltd Appareil chirurgical de pulvérisation d'un adhésif
US7285667B2 (en) * 2005-04-26 2007-10-23 Wyeth Process for the synthesis of functionalized indolizidines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235878A3 (fr) * 1986-01-16 1989-06-14 Beecham Group Plc Nouveaux composés
CA1315276C (fr) * 1987-07-02 1993-03-30 Paul S. Liu Esters et glucosides de castanospermine
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel

Also Published As

Publication number Publication date
EP0449294B1 (fr) 1996-07-10
IL97698A0 (en) 1992-06-21
IE911063A1 (en) 1991-10-09
CA2038984A1 (fr) 1991-10-01
PT97201A (pt) 1991-11-29
KR910016750A (ko) 1991-11-05
HU208974B (en) 1994-02-28
AU638318B2 (en) 1993-06-24
JPH04221382A (ja) 1992-08-11
NO911237D0 (no) 1991-03-26
DE69120705T2 (de) 1996-11-07
EP0449294A1 (fr) 1991-10-02
HU911039D0 (en) 1991-10-28
ES2093040T3 (es) 1996-12-16
CA2038984C (fr) 2002-12-24
DE69120705D1 (de) 1996-08-14
NZ237567A (en) 1994-12-22
FI911510A0 (fi) 1991-03-27
CN1055362A (zh) 1991-10-16
KR100195422B1 (ko) 1999-06-15
JP3019270B2 (ja) 2000-03-13
HUT57209A (en) 1991-11-28
FI911510A (fi) 1991-10-01
ZA912236B (en) 1991-12-24
ATE140228T1 (de) 1996-07-15
US5028614A (en) 1991-07-02
AU7381991A (en) 1991-10-03

Similar Documents

Publication Publication Date Title
HUT53369A (en) Process for producing substituted pyrrole and pharmaceutical compositions containing them
FI883739A (fi) Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi
DE68914488T2 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
DE19975006I2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler St¦rungen.
HU910930D0 (en) Process for the production of 2,8-dioxa-bicyclo/3.2.1/octane derivatives and medical preparations containing them
PL301576A1 (en) Novel hiv protease inhibitors, method of obtaining such inhibitors, pharmaceutical preparation and novel initial compounds
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
NO911237L (no) Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
NO177055C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner
WO1996031208A3 (fr) Utilisation de composes de piperidine ou de pyrrolidine substitues pour le traitement de maladies modulees par un recepteur sigma
PT87704A (pt) Process for preparing pharmaceutical compositions for transdermal delivery containing a 1,4-dihydropyride derivative
AU3473595A (en) Novel phosphane oxides, method of preparing them and drugs containing these compounds
IL98919A0 (en) Substituted piperidines and their use as inhibitors of cholesterol synthesis
ATE128867T1 (de) Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE3770433D1 (de) 4-oxo-1,3-benzodioxan-derivat.
DK13789D0 (da) Ketendithioacetalderivater, fremgangsmaade til fremstilling deraf og praeparater indeholdende saadanne forbindelser.
DE69221649T2 (de) Lacidipin zur Behandlung der Arteriosklerosis
NO881798L (no) Fremgangsmaate for fremstilling av et antiastmapreparat.